Merck Tells Justices Misconduct Doesn't Nix $200M IP Award
The Federal Circuit's extension of a so-called unclean hands defense to wipe out a $200 million patent verdict Merck won against Gilead over hepatitis C drugs after a Merck in-house attorney...To view the full article, register now.
Already a subscriber? Click here to view full article